Benchmarking the paediatric <scp>T</scp> ‐cell <scp>ALL</scp> subtype classifier, <scp>TALLSorts</scp>
Year: 2025
Type: article
Language: en
Topic: Acute Lymphoblastic Leukemia research
Authors and affiliations:
raw_author_name: Ozcan Gulbey
raw_affiliation_strings: Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute Newcastle University  Newcastle upon Tyne UK
Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
raw_author_name: Terena James
raw_affiliation_strings: Illumina Cambridge Ltd.  Cambridge UK
Illumina Cambridge Ltd., Cambridge, UK
raw_author_name: Ruth E. Cranston
raw_affiliation_strings: Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute Newcastle University  Newcastle upon Tyne UK
Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
raw_author_name: Dagmara Furmanczyk
raw_affiliation_strings: Illumina Cambridge Ltd.  Cambridge UK
Illumina Cambridge Ltd., Cambridge, UK
raw_author_name: Claire Schwab
raw_affiliation_strings: Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute Newcastle University  Newcastle upon Tyne UK
Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
raw_author_name: Anna Lawson
raw_affiliation_strings: Cancer Research UK Clinical Trials Unit, School of Medical Sciences, College of Medicine and Health University of Birmingham  Birmingham UK
Cancer Research UK Clinical Trials Unit, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
raw_author_name: Pam Kearns
raw_affiliation_strings: Cancer Research UK Clinical Trials Unit, School of Medical Sciences, College of Medicine and Health University of Birmingham  Birmingham UK
Cancer Research UK Clinical Trials Unit, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
raw_author_name: Ajay Vora
raw_affiliation_strings: Department of Haematology Great Ormond Street Hospital  London UK
Department of Haematology, Great Ormond Street Hospital, London, UK
raw_author_name: Juliette Roels
raw_affiliation_strings: Department of Biomolecular Medicine Ghent University  Ghent Belgium
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
raw_author_name: Pieter Van Vlierberghe
raw_affiliation_strings: Department of Biomolecular Medicine Ghent University  Ghent Belgium
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
raw_author_name: Christine J. Harrison
raw_affiliation_strings: Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute Newcastle University  Newcastle upon Tyne UK
Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
raw_author_name: Mark T. Ross
raw_affiliation_strings: Illumina Cambridge Ltd.  Cambridge UK
Illumina Cambridge Ltd., Cambridge, UK
raw_author_name: Amir Enshaei
raw_affiliation_strings: Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute Newcastle University  Newcastle upon Tyne UK
Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
raw_author_name: Frederik W. van Delft
raw_affiliation_strings: Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute Newcastle University  Newcastle upon Tyne UK
Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
raw_author_name: Anthony V. Moorman
raw_affiliation_strings: Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute Newcastle University  Newcastle upon Tyne UK
Leukaemia Research Cytogenomics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK